Fig. 5From: Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patientsThe Kaplan–Meier survival curve of overall survival (A), progression-free survival (B), and overall survival for T790M negative patients who received different subsequent therapies (C) in NSCLC central nervous system oligoprogessive disease. *p value done by Breslow methodBack to article page